Background {#Sec1}
==========

Methadone is a synthetic opioid that is increasingly used as an analgesic and in maintenance therapy of opioid-addicted patients \[[@CR1], [@CR2]\]. Accidental ingestion of methadone or consumption of its supra-therapeutic doses have been shown to cause multi-organ damage in both humans and animals \[[@CR1], [@CR3]--[@CR5]\].

There have been several previous case reports describing acute-onset encephalopathy (AOE) and delayed-onset leukoencephalopathy (DOL) as adverse complications of methadone intoxication \[[@CR4]--[@CR6]\]. AOE presents with MRI abnormalities within the first admission of the patient. DOL, however, manifests with abnormalities detected on MRI in patients who have initially responded to treatment (complete resolution of symptoms), but are then re-admitted after a period of lucidity (usually days to weeks post the primary event) with neurological or psychiatric deterioration \[[@CR7]--[@CR10]\].

AOE is one of the severe neurologic complications of methadone intoxication, that has previously been associated with carbon monoxide and heroin toxicities \[[@CR7], [@CR8]\]. To date, eight case reports have been published reporting AOE associated with methadone toxicity, ages ranging from 22-month-old to 65 years old \[[@CR1], [@CR4], [@CR5], [@CR11]--[@CR16]\]. These cases have reported a range of neurologic complications, including restrictive diffusion throughout the cerebral gray matter, bilateral diffuse cerebellar edema or infarction, hippocampal and basal ganglia (globus pallidus), fluid-attenuated inversion recovery (FLAIR) intensities, absence of central intracranial blood flow, supra and infratentorial gray matter thickening, and non-enhancing T2 hyperintensities and restriction diffusion in the white matter of both hemispheres with sparing of subcortical U fibers \[[@CR4], [@CR5], [@CR11]--[@CR16]\].

DOL was first described in a 24-year-old patient who developed apathy and disorientation after the initial improvement from a mixed methadone-benzodiazepine poisoning \[[@CR16]\]. Other case studies have reported a range of DOL symptoms, including disorientation, paranoid and bizarre behavior, and severe progressive cognitive decline with bilateral cerebral white matter hyperintensities. MRI changes in these case reports have included diffuse abnormal T2 and FLAIR signals in the corona radiate, centrum semiovale and subcortical white matter throughout all lobes, and signal abnormalities in temporomesial, substantia nigra, and basal ganglia \[[@CR6], [@CR8], [@CR9], [@CR12], [@CR13], [@CR17]--[@CR21]\]. The aim of our study was to identify and describe the pattern of neurological deficits and associated brain magnetic resonance imaging (MRI) changes in methadone-poisoned patients.

Methods {#Sec2}
=======

In this retrospective file audit, the clinical records of all patients admitted to our referral poisoning hospital with the diagnosis of methadone intoxication between May 2016 and March 2018 were reviewed. A total of 2930 cases were identified, of whom only 10 fulfilled the inclusion criteria.

Definitions {#Sec3}
-----------

Methadone intoxication was defined based on history, clinical presentations of respiratory depression (opioid toxidrome) or loss of consciousness (LOC) responsive to administration of naloxone, as well as detection of methadone in urine analysis. The patients were classified into two subtypes: acute- and delayed-onset encephalopathy (AOE and DOL, respectively) based on clinical history. Patients with persistent neurological deficits in their first admission were categorized to have AOE based on their MRI changes. Those who had been discharged after either complete or partial recovery from acute intoxication, but then deteriorated with neurological signs or symptoms within several days or weeks necessitating readmission were considered to have DOL \[[@CR7]--[@CR9]\]. The most prevalent delayed symptoms included psychotic delirium, fluctuating state of consciousness, depression, apathy, and bizarre behaviors \[[@CR9]--[@CR13]\]. Complete knowledge of time courses and clinical presentation was a prerequisite in categorization of the patients. Imaging was performed due to persistent neurological deficits several days after admission or if there was re-occurrence of neurotoxicity after a lucid interval of at least 1 week.

Inclusion criteria {#Sec4}
------------------

AOE: Patients who had been admitted due to methadone intoxication and had undergone imaging due to persistent neurological deficits were enrolled in AOE group.

DOL: Neurological deficits were defined as a deterioration of neurologic function leading to readmission within one to 3 weeks after discharge without any new toxic exposure. Patients fulfilling this criteria were enrolled into the DOL group.

Exclusion criteria {#Sec5}
------------------

If methadone diagnosis was not confirmed after the review of the history, presentation, and urine analysis. Patients who had co-ingestions confirmed by urine analysis were also excluded (e.g. Alcohol). Any cases with possible intoxication, with a coingestants known to cause MRI complications (carbon monoxide \[CO\], methanol, cyanide, etc.) were excluded.

Imaging {#Sec6}
-------

Scans were performed by a 1.5-T multi-planar MRI device. Echo planar T1 (TR: 591 ms, TE:15 ms, Spatial Resolution: 6.2 mm slice thickness, FoV: 230 mm\*230 mm), T2 (TR: 4048 ms, TE:90 ms, Spatial Resolution: FLAIR, diffusion weighted imaging (DWI) and apparent deficient coefficient (ADC) sequences without contrast media were performed. The scan time was 15 min. All images were reviewed by a single radiologist experienced in MRI. Detected abnormalities were recorded and categorized based on their anatomic location and sequence. The areas with both restriction in DWI and low signal in abnormal diffusion restriction (ADC) were considered abnormal.

Results {#Sec7}
=======

Eight patients had a brain MRI performed during their first admission due to persistent neurological deficit despite active treatment (AOE group; Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}). This group included four children (aged 23 months to 16 years) who had accidentally ingested methadone. The other two had developed new neurological deficits days after the initial recovery from intoxication (DOL group; Table [3](#Tab3){ref-type="table"}). All ten patients had abnormal findings on MRI. Table 1Clinical characteristics of patients with AOEPatient numberAge/ SexInitial presentationUrine toxicologyTime to imaging113 yr, FCyanosisMethadoneDay 5216 yr, FApneaMethadoneDay 7323mo, MCyanosisMethadone, benzodiazepineDay 5430 yr, MIntoxication then witnessed apneaMethadoneDay 2531 yr, MConfusion then witnessed apneaMethadone, opiateDay 12632 yr, FLOCMethadoneDay 3733 yr, MLOCMethadone, opiateDay 285 yr, MLOCMethadoneDay 2 Table 2Brain MRI findings in patients with AOENumberAge/ SexBilateral cerebral white matter T2 and FLAIR hyperintensityBilateral cerebellar white and gray matter T2 and FLAIR hyperintensityBilateral parieto-occipital T2 and FLAIR hyperintensity (PRES features)Internal capsule involvementOther structuresInfarctionHemorrhage113 yr, FYesYesYes----NoNo216 yr, FYes--------NoNo323mo, MYes--------NoNo430 yr, M--YesYesWith restriction in DWI and low signal in ADC sequences----NoNo531 yr, MYes----YesSplenium of corpus callosumNoNo632 yr, F----YesWith restriction in DWI and low signal in ADC sequences----NoNo733 yr, MYes----Yes with restriction in DWI and ADC sequences--NoNo85 yr, M--YesYesWith restriction in DWI and low signal in ADC sequences--Globus pallidus and caudate nucleiNoNo Table 3Clinical characteristics and brain MRI findings of patients with DOLNumberAge/ SexToxic agentClinical presentation in relapse phaseTime to relapse after initial intoxicationInitial imagingDelayed phase brain MRI findingsDWI and ADC947 yr, MMethadoneDisorientation, seizure like activity9 daysNoConfluent bilateral symmetrical cerebral white matter T2 and FLAIR hyperintensity with sparing of sub cortical U-fibersNo restriction1049 yr, MMethadoneConfusion18 daysNoConfluent bilateral symmetrical cerebral white matter T2 and FLAIR hyperintensity with sparing of sub cortical U-fibersNo restriction

AOE group {#Sec8}
---------

Seven patients in this group were male and median age was 23 years \[range; 23 months to 33 years). Based on urine analysis, three cases had positive urine for other drugs. One had received benzodiazepine as a part of medical management. Other two were multi-opioid abusers, but had only overdosed on methadone. Imaging findings in this group included bilateral confluent or patchy T2 and FLAIR high signal intensity areas in cerebral white matter in six (Fig. [1](#Fig1){ref-type="fig"}), cerebellar involvement in four (Fig. [2](#Fig2){ref-type="fig"}), and bilateral occipitoparietal cortex signal abnormality (low on T1 and high on T2) associated with diffusion restriction (confirmed with low signal intensity in ADC) in three cases (Fig. [3](#Fig3){ref-type="fig"}) and without restriction in one case. Internal capsule involvement was detected in two patients with hyper-signal corpus callosum in one. Abnormalities in the globus pallidus and the head of caudate nuclei were reported in only one patient. The MRIs were performed at 2- and 12-day intervals after initial presentation with methadone intoxication (defined as the primary toxic event). Fig. 1Axial (**a**) T2 and (**b**) FLAIR sequences of a 31-year-old man (patient number 5) , 12 days after presenting to emergency department with AOE symptoms, symmetric areas of hyperintensity in both centrum semiovale are seen. Axial (**c**) and (**d**) FLAIR sequences of the same patient at the mid ventricular level show hyperintensity in the splenium of corpus callosum Fig. 2Axial (**a**) T2 and (**b**) FLAIR sequences from posterior fossa at the level of fourth ventricle in a 30 year old male ( patient number 4) two days after primary symptoms of AOE, high signal areas are seen in posterior part of cerebellum with gray and white mater involvement Fig. 3Axial (**a**) T2 and (**b**) FLAIR sequences of a 5- year-old boy (patient number 8) , two days after initial presentation of AOE , bilateral symmetric hyperintense areas are seen in basal ganglia (globus pallidus and head of caudate) in keeping with cortical and subcortical hyperintense areas in occipital lobes which has restricted in DWI (**c**) with low ADC signal (**d**)

DOL group {#Sec9}
---------

The two patients in this group were 47 and 49 years old and had a 9- and 18-day lucid interval, respectively, between the initial presentation and clinical relapse (Table [3](#Tab3){ref-type="table"}). Confluent bilateral symmetrical cerebral white matter signal abnormality with sparing of subcortical U-fibers on T2 and FLAIR sequences were observed in both of these patients (Fig. [4](#Fig4){ref-type="fig"}). Fig. 4Axial (**a**) T2 and (**b**) FLAIR sequences in a 47-year-old male with DOE (patient number 9) above the ventricular level show confluent bilateral symmetrical cerebral white mater hyperintensity with sparing of subcortical U-fibers. Axial (**c**) DWI and (**d**) ADC sequences also show T2 shine through phenomenon without any evidence of diffusion restriction

Discussion {#Sec10}
==========

Methadone-induced encephalopathy is a rare event. To date, this phenomenon remains poorly characterized \[[@CR4], [@CR5], [@CR21]\]. The brain MRI changes reported in the literature are summarized in Table [4](#Tab4){ref-type="table"} and include: cerebellum abnormalities \[[@CR1], [@CR4], [@CR10]--[@CR14]\], bilateral cerebral white matter abnormalities \[[@CR4], [@CR5], [@CR11], [@CR12], [@CR14]\], signal changes in hippocampus \[[@CR10]\], globus pallidus \[[@CR13]\], and in a single case report in the head of caudate nuclei \[[@CR4]\]. In addition, there is a single case report of a 2-year-old infant found to have cerebral white matter, cerebellar, and globus pallidus hypodensities based on computed tomography (CT) scan \[[@CR22]\]. Table 4Summary of published case reports of AOEAuthor(s)Age/sexClinical presentationClinical findings in dischargeLab DataTime to imagingMRI findingsAnselmo M. Et al (2005) \[[@CR10]\]3yo, MLOC, irregular breathing, low BPMild AtaxiaUrine toxicology: positive for methadone after 36 hDay 6High T2 in cerebellar hemispheres and hippocampusMills F. Et al (2008) \[[@CR11]\]3yo, FLOC, hard breathing, hypothermiaSpastic dysplasia and dystoniaUrine toxicology: positive for methadoneDay 2FLAIR: damage to gray matter and white matter of cerebellum with marked swellingRiascos R (2008) \[[@CR12]\]22mo,-LOCBrain deathUrine toxicology: positive for methadone, acetaminophen and salicylateIn admission dayDiffuse bilateral cerebellar infarction, absence of central intra cranial blood flow, supra and infra tentorial gray matter thickeningCorré J. Et al (2013) \[[@CR13]\]29yo, MLOC, hypothermia, bradypneaGood recovery, except persistent renal failure and kinetic cerebellar syndromeBlood analysis was positive for alcohol, cannabis, methadone (146 ng/ml), and benzodiazepinesAt first day of admission.FLAIR and DWI: high in both cerebellar and basal ganglia (globus pallidus)Metkees M. Et al (2015) \[[@CR14]\]15yo, FLOC, hypothermia, hypercapnia, HTNDeathDetailed history revealed methadone ingestion of unknown quantityNot mentionedT2 and DWI: high in white matter of both hemisphere (sparing sub cortical U-fibers and deep gray matter, cortical or cerebellar)Cerase A. Et al (2011) \[[@CR4]\]49yo, MLOCComplete recovery after 3 mo.Serum toxicology: positive for methadoneNot mentionedT2 and FLAIR: high in white matter of right cerebellum and deep gray and white matter of both cerebral hemispheres.R.A. Salgado et al. (2009) \[[@CR5]\]65yo, FApathy, a catatonic state with extreme rigidity, reflexes in the upper limbs, and a bilaterally positive Babinski signIn the following month, the patient slowly recovered.Serum and urine toxicology shows large amount of methadoneDay 27FLAIR and T2: symmetric signal intensity abnormality in the deep white matter of both cerebral hemisphere with sparing of sub cortical U-fibers without corresponding diffusion restrictionRando J. (2016) \[[@CR1]\]14yo, MHypothermia, HTN, respiratory depressionAphasia, truncal ataxiaSerum toxicology: positive for methadoneIn admission dayFLAIR: cereberallitis

In our AOE patients, the most frequent MRI finding was bilateral confluent or patchy cerebral white matter hyperintensity (*n* = 5). Cerebellar abnormalities were detected in only three cases despite this was the most common observed abnormality in previous studies \[[@CR1], [@CR10], [@CR13]\]. A consistent (*n* = 4) and new finding in these patients was bilateral parieto-occipital cortex T2 and FLAIR hyperintensity. This radiological finding has also been reported in patients with posterior reversible encephalopathy syndrome (PRES \[[@CR23]\];). PRES has been reported as a consequence of or in conjunction with a variety of critical illness states including severe hypertension, hemolytic-uremic syndrome, thrombocytopenic thrombotic purpura, and in association with drug toxicities such as cisplatin, cyclophosphamide, interferon \[[@CR23]--[@CR25]\], and opiates such as morphine \[[@CR26], [@CR27]\]. In keeping with the findings in PRES, three of our patients had bilateral parieto-occipital cortex restriction in DWI which was confirmed by ADC sequence. Additionally, restriction was observed in one patient with internal capsule involvement (case 7). Restriction in bilateral cerebral white matter has previously been reported secondary to methadone toxicity \[[@CR4], [@CR11]\]. One study suggested that "deep watershed infarct" resulted in the restriction imaging observed \[[@CR11]\]. Given our observations and previous published reports, it can be postulated that the changes in AOE due to methadone could result in PRES.

We also had two patients who had internal capsule involvement. This finding is in accordance with previously published reports as a characteristic of heroin toxicity \[[@CR28]\]. In our both patients, morphine and methadone were detected in urine analysis. Therefore, heroin use cannot be ruled out. Additional confirmatory testing for supplementary heroin metabolites would have been useful in these two individuals. However this was not available in our center. One of them (Case 5) demonstrated lesions in splenium of corpus callosum, a finding never reported before in either heroin or methadone intoxication. This finding may be a transient lesion of splenium and has been associated with various clinical conditions such as seizures, metabolic disturbances, infections, CNS malignancy, and drugs and toxins (antidepressants, antiepileptics, antipsychotics, chemotherapy agents, and pesticides) \[[@CR15], [@CR28]--[@CR38]\]. We also had a single patient (case 8) who showed involvement of the globus pallidus and head of caudate nuclei. This finding has been observed in association with methadone toxicity \[[@CR4], [@CR13]\]. Previously, brain imaging changes associated with methadone intoxication were suggested to be as a consequence of hypoxic events secondary to overdose \[[@CR12]\]. However, hypoxia-associated cerebral adverse effects on imaging seem to be only a result of prolonged hypoxia \[[@CR39], [@CR40]\]. Majority of our patients did not have a persistent documented hypoxic insult. Brain neuroimaging was performed on admission, and before the worsening of patient's condition. Secondly, brain and cerebellar damage demonstrated at both diagnosis and follow-up showed a clear-cut prominent involvement of the subcortical white matter. In adulthood, hypoxic-ischemic insults usually result in watershed zone infarcts when mild to moderate, and affect the gray matter in the basal ganglia, thalami, cerebral cortex, cerebellum, and hippocampi when severe. Furthermore, severe insult generally includes a stage of diffuse cerebral edema with loss of differentiation between gray and white matter, a finding that was not noted in the patients reported. Furthermore, acute and early subacute phases of hypoxia-induced encephalopathy primarily affect the basal ganglia, thalamus, and cortex \[[@CR41]\]. We reported bilateral cerebral white matter and cerebellum abnormalities as the most common brain MRI finding.

To date, only 8 case reports evaluating 11 patients have been published reporting delayed-onset methadone-induced leukoencephalopathy \[[@CR6], [@CR10], [@CR16]--[@CR20]\], summarized in Table [5](#Tab5){ref-type="table"}. The most frequent imaging findings in case reports of patients with DOL is bilateral cerebral white matter T2 and FLAIR hyperintensity \[[@CR6], [@CR8], [@CR9], [@CR16], [@CR18], [@CR20]\] followed by corpus callosum \[[@CR9], [@CR16]\] and globus pallidus \[[@CR8]\] involvement. This is in keeping with our observation of bilateral cerebral white matter hyperintensity. However, the findings in DOL group are not generalizable, as there were only two cases in this group, who also lacked imaging in their acute phase for comparison with the DOL phase imaging. Furthermore, during examination of DWI and ADC, no restriction was found in either case. Four patients have been described with restriction in DWI scans, although a correlation with ADC was not reported in them \[[@CR9], [@CR17], [@CR18], [@CR20]\]. It is possible that the restrictions observed in these patients is related to T2 shine through, as this phenomenon has also been observed in our patients. Table 5Summary of published works on DOLAuthor(s) yearAge/ SexToxic agentTime to relapse after initial intoxicationClinical presentation in relapse phaseFirst imaging findingsDelayed phase MRI findingsDWI and ADC sequences findingsPrognosisLjungar B. et al. 2014 \[[@CR17]\]34 yr, MMethadone33 daysPhysical, psychological and cognitive deteriorationCerebral white matter T2 hyperintensityCystic changes in bilateral cerebral white matterHyperintensity in DWI without ADC confirmationRecoveryMittal M. et al. 2010 \[[@CR6]\]38 yr, MMethadone, benzodiazepine3 weeksPhysical, psychological and behavioral manifestationsNo imagingCerebral white matter T2 hyperintensityNo restrictionPartial recoveryArciniegas 2004 \[[@CR16]\]24 yr, MMethadone, diazepamNot mentionedApathy, disorientationNo imagingCerebral white matter and corpus callosum T2 hyperintensityNot mentionedPartial recoveryTorralba A- Moron 2016 \[[@CR8]\]42 yr, MMethadone, alcohol, benzodiazepine13 daysMyoclonus, fluctuated consciousness,Normal CT scanCerebral white matter and globous pallidus T2 hyperintensityNot mentionedLack of attention and dysexecutive and amnestic abnormalities persisted43 yr, MMethadoneNot mentionedlow level of consciousness and a bradypnoeaNot mentionedCerebral white matter and globous pallidus T2 hyperintensityNot mentioneddeathZanin A. 2010 \[[@CR19]\]30mo, FMethadone19 daysAgitation, slurred speech, abnormal movementNormalTempromesial, Substantia Nigra and basal gangliaNo restrictionRecovery after 2 monthAndrew Meyer M. 2013 \[[@CR20]\]43 yr, FMethadone, diazepam3 weeksForgetful& confused, social withdrawal, lack of hygieneNo imagingCerebral white matter T2 hyperintensityHyperintensity in DWI without ADC confirmationRecoveryCarroll I. 2012 \[[@CR9]\]43 yr, FAlprazolam, methadone33 daysApathy, inappropriate behaviorNo imagingCerebral white matter and corpus callosum T2 hyperintensityCorpus Collosum hyperintensity in DWI without ADC confirmationFull recovery after 6 monthShprecher D. 2008 \[[@CR18]\]39 yr, FMethadone, cocaine4 weeksdisorientationNo imagingCerebral white matter T2 hyperintensityHyperintensity in DWI without ADC confirmationPartial recovery58 yr, Fmethadone21 daysParanoid and inappropriate behavioralNo imagingCerebral white matter T2 hyperintensityNot mentionedPartial recovery56 yr, FMethadone, fentanyl, benzodiazepine15 daysCognitive deteriorationNot mentionedCerebral white matter T2 hyperintensityHyperintensity in DWI without ADC confirmationPartial recovery

Almost all published case reports to date are in adult patients, except for a single case of 30-month-old infant. There are no previous publications on DOL due to other reasons (strangulation, CO poisoning, benzodiazepine overdose, etc.) in adults younger than 30 years \[[@CR7]\]. Since both of our patients were also adults, it is possible that DOL is a phenomenon more common among adult patients. DOL has been previously suggested to be due to hypoxia \[[@CR6], [@CR16]\]. However, given that neither of our patients had history of prolonged unconsciousness or respiratory depression, hypoxia as an etiology can be excluded. The lucid intervals of one to 5 weeks have been reported in earlier case reports \[[@CR7]\], which was reinforced with our cases.

Conclusion {#Sec11}
==========

Methadone intoxication can result in a spectrum of encephalopathies ranging from AOE to DOL which can be diagnosed using MRI findings. Future studies on larger sample sizes are required to elucidate this association with its possible imaging findings. Our study is the first to demonstrate that MRI changes due to methadone intoxication can parallel those observed in PRES in both adults and children. Given that both heroin and morphine have been previously reported to present with changes suggestive of PRES, it is reasonable to extrapolate this to be an opioid class effect. In DOL, bilateral T2 and FLAIR white matter hyperintensity was the common finding. Therefore, in patients with a recent history of methadone intoxication who represent with relapsing neurological symptoms, DOL needs to be considered.
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